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Objectives: Typically, obesity results from an inappropriate balance between energy uptake from nutrient consumption and burning of calories,
which leads to a pathological increase in fat mass. Obesity is a major cause of insulin resistance and diabetes. Inhibitory G proteins (Gai) form a
subfamily that is involved in the regulation of adipose tissue function. Among the three Gai members, i.e. Gai1, Gai2, Gai3, the Gai2, protein is
predominantly expressed in adipose tissue. However, the functions of the Gai2 isoform in adipose tissue and its impact on the development of
obesity are poorly understood.
Methods: By using AdipoqCreERT2 mice, we generated adipocyte-specific Gnai2-deficient mice to study Gai2 function, specifically in white and
brown adipocytes. These mice were fed either a control diet (CD) or a high fat diet (HFD). Mice were examined for obesity development, insulin
resistance and glucose intolerance. We examined adipocyte morphology and the development of inflammation in the white adipose tissue. Finally,
intracellular cAMP levels as an indicator of Gai signaling and glycerol release as an indicator of lipolysis rates were measured to verify the impact
of Gai2 on the signaling pathway in brown and white adipocytes.
Results: An adipocyte-specific deficiency of Gai2 significantly reduced diet-induced obesity, leading to decreased fat masses, smaller adipo-
cytes and decreased inflammation in the white adipose tissue relative to littermate controls. Concurrently, oxygen consumption of brown adi-
pocytes and in vivo measured energy expenditure were significantly enhanced. In addition, glucose tolerance and insulin sensitivity of HFD-fed
adipocyte-specific Gnai2-deficient mice were improved compared to the respective controls. In the absence of Gai2, adrenergic stimulation of
intracellular adipocyte cAMP levels was increased, which correlated with increased lipolysis and energy expenditure.
Conclusion: We conclude that adipocyte Gai2 is a major regulator of adipocyte lipid content in diet-induced obesity by inhibiting adipocyte
lipolysis in a cAMP-dependent manner resulting in increased energy expenditure.
 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Obesity is a rapidly expanding pandemic disorder, which associates
with severe comorbidities such as metabolic syndrome, cardiovascular
disease and certain types of cancer. Obesity results from an imbalance
between energy intake and energy expenditure, leading to an increase
in body fat mass with adipocyte hypertrophy and hyperplasia. Exces-
sive lipid storage is associated with chronic inflammation of adipose
tissue, which is considered to be a major cause of obesity-related
insulin resistance and type-2 diabetes [1e4]. G-protein-coupled re-
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that are involved in the control of metabolism such as the central
nervous system, liver, muscle, pancreatic islets, and adipose tissue [5].
The transmembrane signal transduction from ligand-activated re-
ceptors to intracellular effector proteins is mediated via heterotrimeric
G proteins, which consist of three subunits (Ga, Gb and Gg). Upon
binding of a ligand to a GPCR, the associated heterotrimeric G protein is
activated, leading to a dissociation of both the Ga subunit as well as the
Gbg dimer from its receptor. The G protein subunits elicit cellular
responses through regulation of intracellular second messenger sys-
tems. The pertussis toxin (PTX)-sensitive Gai family is implicated inCenter of Pharmacoge-nomics and Drug Research, University of Tübingen, 72074,
127, Bonn, Germany 3Department of Internal Medicine, Division of Endocrinology,
en, Tuebingen, Germany 4German Center for Diabetes Research (DZD), Neuherberg,
nter Munich at the University of Tuebingen (IDM), Tuebingen, Germany 6Section on
rsity of Tuebingen, Germany 7Neurobiology Laboratory, National Institute of Envi-
of Biomedical Research (BIOMED), Catholic University of Argentina, Buenos Aires,
logy, University of Tübingen, Wilhelmstr. 56, 72074, Tübingen, Germany. Tel.: þ49
 Available online 30 May 2020
ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 1
Original Articlemetabolic signaling pathways to control physiological and pathophys-
iological conditions [1e4]. The three Gai isoforms (Gai1, Gai2, Gai3),
which are encoded by the genes Gnai1, Gnai2, and Gnai3, respectively,
have been described as inhibitory Ga subunits that suppress adenylyl
cyclase activity, resulting in decreased intracellular cAMP levels [6].
The Gai protein family shows a sequence homology of 85e95%.
Because of this close similarity, it has been suggested that Gai proteins
have identical functions and play redundant physiological roles. How-
ever, recent studies in mice with global or cell-specific absence of Gai-
isoforms highlighted their distinct biological roles [7e13]. Global
Gnai2-deficiency results in retarded embryonic growth and reduced
weight [9,12,14], defective inflammation-induced macrophage
migration [12,13], and reduction in L-arginine-induced insulin secretion
[9]. Although Gai2 is ubiquitously expressed, its role in cell-type spe-
cific functions, especially regarding lipid metabolism and body weight,
remains to be clarified. Although all three Gai isoforms are found in
adipose tissue, Gai2 is the major isoform in brown (BAT) and white
adipose tissue (WAT) but the specific impact and the consequences of
Gai2 expression in adipocytes needs to be determined.
Here, we studied mice lacking the Gai2 protein specifically in adipo-
cytes (Gnai2ako) by using AdipoqCreERT2 mice. The Cre recombinase
expression was under the control of the Adiponectin promotor and
recombination had to be induced with tamoxifen injections [15]. To
examine the role of Gai2 in BAT and WAT, we challenged these
Gnai2ako mice with a 45% high fat diet (HFD) in comparison to their
littermate controls. Lack of adipocyte Gai2 mitigated diet-induced
obesity and resulted in a significant reduction of inflammatory pa-
rameters (IL-6, TNFa, crown-like structure formation), improved
glucose tolerance and insulin sensitivity. Gnai2-deficient adipocytes in
subcutaneous and visceral WAT of mice on HFD were smaller and
showed reduced fat storage in these adipose tissue compartments.
Lack of Gai2 in both, brown and white adipocytes caused elevated
cAMP levels and lipolytic activity, which was reflected in increased
energy expenditure.
These findings identify adipocyte Gai2edependent signaling to be
crucial in the development of obesity and insulin resistance. We
therefore conclude that Gai2 has an isoform-specific function in brown
and white adipocytes. Importantly, none of the remaining Gai isoforms
compensated for the missing Gai2. In fact, Gai2-deficiency increased
lipolytic activity of brown and white adipocytes in a cAMP-dependent
manner, which is likely to explain an increased energy expenditure
and a significantly reduced weight gain under high caloric conditions.
2. METHODS
2.1. Animals and diets
To obtain a tissue-specific deletion of Gai2 in adipocytes (Gnai2
ako),
mice on a C57BL/6N background, carrying a tamoxifen-inducible
adipose tissue-specific Cre recombinase under the control of the
adiponectin promoter (genotype adiponectin-CreERT2þ/tg), were
mated to homozygous animals of the floxed Gnai2 mouse line (ge-
notype Gnai2fl/fl) [7,9,15].
Genotyping was performed using specific primers to identify the Cre
transgenes as well as the floxed and wild-type alleles of Gnai2 on DNA
samples obtained from ear or tail-tip biopsies. Premutant animals
(genotype Gnai2fl/fl; adiponectin-CreERT2þ/tg) and their littermate
controls (ctrl; genotype Gnai2fl/fl) derived from the respective breeding
were injected with tamoxifen (1 mg/day) for 5 consecutive days at an
age of 4 weeks to induce Cre-mediated recombination [15,16].
Before administering the different research diets, all experimental mice
received a commercial standard chow (SNIFF). Starting at the age of 62 MOLECULAR METABOLISM 40 (2020) 101029  2020 The Authors. Published by Elsevier GmbH. Tweeks, dietary feeding trials were performed in male mice that
received either a defined control diet (CD) formulation containing 10%
of calories from fat or a high-fat diet (HFD) containing 45% of calories
from fat (both obtained from Research Diets, New Brunswick, NJ, USA)
for another 22 weeks. Progressive body weight gain was monitored
weekly. During the studies, animals had free access to drinking water.
All animal experiments were approved by the local government’s
Committee on Animal Care and Welfare and conducted in accordance
with the German legislation on the protection of animals. All mice
analyzed within this study were bred and maintained in the animal fa-
cility of the Institute of Experimental and Clinical Pharmacology and
Pharmacogenomics, Eberhard Karls University, Tübingen. They were
housed in individually ventilated cages (IVC) under specific-pathogen-
free conditions with temperatures maintained between 21 C and
24 C, humidity at 45e55% and a 12-h light/dark cycle. All experi-
mental protocols were based on the institutional guidelines of the Vet-
erinary Care Unit, University of Tübingen and Bonn and were approved
by the animal welfare commissioner of the regional board for scientific
animal experiments in Tübingen and Bonn. Experiments were performed
according to the European Union Directive 86/609/EEC for the protection
of animals used for experimental and other scientific purposes.
2.2. Food and water intake
For measurement of food and water intake, mice were housed indi-
vidually. Food consumption was assessed on four consecutive days.
The amount of food and water consumed by each individual mouse
was determined by calculating the weight differences between the
initial weight of the food pellets or water bottle and the final weight
24 h later.
2.3. Bomb calorimetry
Energy excreted in feces was measured using a bomb calorimeter
(Parr Instrument Company model 6725).
2.4. Magnetic resonance imaging
For quantification of fat volume, magnetic resonance imaging (MRI)
studies were performed on a 3 T whole-body imager (Magnetom Trio,
Siemens Healthcare, Erlangen, Germany). Mice were anaesthetized
with ketamine (2 mg)/xylazine (0.4%) and were positioned in prone
position in the wrist coil of the manufacturer and MRI examinations
were simultaneously performed in Gnai2ako mice and their respective
control (ctrl) littermates. An in-plane spatial resolution of 0.4 mm and a
slice thickness of 2 mm allowed recording of abdominal fat images.
The fat volume was calculated as described in [17,18].
2.5. Time-domain-nuclear magnetic resonance analysis
Fat mass, lean mass and extracellular fluid were analyzed using time-
domain-nuclear magnetic resonance analysis (TD-NMR; LF50; Bruker,
Massachusetts, USA) in mice.
2.6. Energy expenditure
Energy expenditure was measured individually over 24 h with Phe-
nomaster/TSE Systems (Bad Homburg, Germany). Mice were allowed
to acclimate to metabolic chambers for 24 h before measurements.
2.7. Adipose tissue mass
To determine masses of different fat depots, all pads of brown adipose
tissue (BAT), gonadal white adipose tissue (gWAT) and inguinal white
adipose tissue (iWAT) were dissected, weighed as a whole, before
being cut into smaller pieces, immersed in liquid nitrogen and finally
stored at 80 C for further analysis.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.8. PCR analysis
PCR amplification was performed with specific primers to identify the
Cre transgene, the floxed and the wild-type allele of Gnai2, after
extraction of DNA from different tissues of Gnai2ako mice, as well as
adipocytes of various other genotypes using a lysis buffer containing
proteinase K.
DNA samples were separated by size via agarose gel electrophoresis
using a 2% agarose gel stained with ethidium bromide.
2.9. RNA isolation and qPCR
Total RNA was isolated from tissues using TRIzol (peqLab). Reverse
transcription was performed using Transcriptor First Strand Synthesis
Kit (Roche). qPCR was performed using SYBR-Green (Roche) and a Light
Cycler 480 instrument (Roche). Fold changes were calculated using
relative quantification methods with b-actin serving as internal control.
2.10. Immunoblot analysis
Dissected BAT, gWAT and iWAT pads were homogenized in lysis buffer
containing 100 mM NaCl, 20 mM TriseHCl, 2.5 mM EDTA and pro-
tease inhibitors (Complete Roche; Roche, Mannheim, Germany) to
generate total protein lysates for subsequent immunoblot analyses.
The proteins were precipitated with a 3:1 ratio of methanol to chlo-
roform prior to separation by molecular weight via 12% SDS gels
containing 6 M urea to achieve proper electrophoretic separation of Gai
isoforms, and subsequently transferred onto polyvinylidene difluoride
membranes (PVDF; Merck Millipore, Darmstadt, Germany). The
membranes were blocked in 5% milkeTBST (tris-buffered saline
(TBS)eTween 20), incubated with the indicated antibodies and
developed with enhanced chemiluminescence (ECL; GE Healthcare,
Buckinghamshire, UK).
For immunodetection of Gai1 and Gai2 proteins, the following primary
antibody was used directed against the very last 21 amino acids of the
C-terminus: rabbit anti-Gai1/i2 (1:5000) [9,14,19,20]. Loading controls
were performed with antibodies against mouse anti-b-actin (1:5000;
SigmaeAldrich, Taufkirchen, Germany). As secondary antibodies, anti-
rabbit HRP (1:2000; Cell Signaling Technology, Danvers, MA, USA) and
anti-mouse HRP (1:2000; Dako, Glostrup, Denmark) were applied. The
protein levels of Gai1 and Gai2 were quantified using densitometric
analysis software (Image Lab; Bio-Rad, Hercules, CA, USA) and
normalized to the b-actin levels of the same samples.
The analyses were run in three independent experiments for each
animal analyzed. The mean values for the single probes were built and
overall mean was calculated.
2.11. Glucose and insulin tolerance test
For the glucose tolerance test, mice were fasted overnight. Blood
glucose levels were determined using a Contour XT glucometer
(Bayer, Leverkusen, Germany) immediately before an intraperitoneal
(i.p.) injection of glucose (2 mg/g body weight) and 15, 30, 60 and
120 min after the injection. At each time point, additional blood
samples were collected via the tail vein for subsequent insulin
determination.
For the insulin tolerance test, mice were fasted for 4 h, followed by an
i.p. injection of insulin (1 mU/g body weight). 1.5 mM aprotinin was
added to the blood samples. Blood glucose levels were measured
before the injection and 15, 30, 60 and 120 min after using a Con-
tour XT glucometer (Bayer, Leverkusen, Germany).
2.12. Blood parameters
Plasma levels of insulin were measured using a commercially available
insulin ELISA method (Mercodia, Uppsala, Sweden). Leptin, resistin,MOLECULAR METABOLISM 40 (2020) 101029  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.cominterleukin 10 (IL-10) and tumor necrosis factor alpha (TNFa) con-
centrations were measured in plasma samples using Bio-Rad Bio-
Plex Multiplex Immunoassays (Bio-Rad, Hercules, USA), according to
the manufacturer’s instructions.
2.13. Adipose tissue histology
To quantify adipocyte area, fat pads were isolated and fixed in 4%
paraformaldehyde for 24 h. Samples were dehydrated through graded
ethanol and embedded in paraffin. Serial 6 mm thick sections of gWAT
and iWAT were prepared and stained with hematoxylin and eosin
(H&E). Images (20 magnification) were acquired using the Zeiss Axio
Imager M2 microscope (Carl Zeiss, Jena, Germany). Adipocyte area
was measured from digital images with the AxioVision software
version 4.8 (Carl Zeiss, Jena, Germany).
For F4/80 immunohistochemistry, slices were deparaffinized and
rehydrated. Antigen retrieval was performed by boiling samples in
citrate buffer pH 6 (0.1 M citric acid and 0.1 M sodium citrate). Sec-
tions were treated with 3% hydrogen peroxide and then incubated in
5% normal goat serum in PBS (blocking solution). After overnight in-
cubation at 4 C with the primary antibody (rat-anti-mouse F4/80;
1:500; Bio-Rad) and subsequent incubation with an anti-rat-
biotinylated secondary antibody (1:500; Dako) for 30 min at room
temperature, detection was performed using avidin-biotin complex
(Vectastain Elite ABC Kit; Vector Laboratories, Burlingame, CA, USA)
and 0.05% 3,30-diaminobenzidine (DAB). For quantification of crown
like structures (CLS), adipocytes and the number of CLS were counted
in at least three different sections for every animal using the AxioVision
software.
2.14. Oil Red O staining
Livers were fixed in PBS containing 4% paraformaldehyde. After
washing with PBS, liver slices were incubated with Oil Red O (Sigmae
Aldrich, St. Louis, USA) solution (3 mg/ml in 60% isopropyl alcohol) for
15 min at room temperature, washed with PBS, and visualized under
the microscope.
2.15. Lipolysis and cAMP measurements
Fat pads were harvested and cut into small pieces, which were
weighed and incubated in 600 ml of lipolysis medium (Gibco
DMEM 21063, Thermo Fisher Scientific, Waltham, MA, USA; sup-
plemented with 2% BSA) either without additive or 10 mM isopro-
terenol. After 1 h of incubation at 37 C, medium was collected,
followed by determination of the glycerol concentration using a free
glycerol assay kit (Abcam, Cambridge, UK), according to the man-
ufacturer’s instructions. Sample absorbance was measured at
570 nm using the Tecan Sunrise microplate reader (Tecan, Män-
nedorf, Switzerland). Glycerol content was normalized to the initial
tissue weight.
For cAMP measurement, fat pads were treated in an analogous
manner and incubated in medium additionally supplemented with
1 mM 3-isobutyl-1-methylxanthine (IBMX) and containing the
respective additives for 15 min. Adipose tissue pieces were collected
after incubation and frozen in liquid nitrogen. Subsequently, the
intracellular content of cAMP was detected with a cAMP competitive
enzyme immunoassay (R&D Systems, Minneapolis, MN, USA), ac-
cording to the manufacturer’s instructions.
2.16. Seahorse assay
To measure oxygen consumption rate (OCR), an indicator of mito-
chondrial respiration, we used the state-of-the-art Seahorse Extra-
cellular Flux (XF) 96 Analyzer (Seahorse Bioscience, North Billerica,ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
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linked respiration, proton leak respiration and reserve capacity were
determined for each parameter in three repeated rates over a 20 min
period. Baseline cellular oxygen consumption was measured by sub-
tracting non-mitochondrial respiration.
2.17. Triglyceride content
To determine triglyceride content in liver, gWAT and iWAT the tissue
was homogenized in ddH2O supplemented with 5% NP-40. The
samples were heated to 80 C for 5 min, cooled down to room tem-
perature and TG content was measured according to the manufac-
turer’s instructions (Abcam, Cambridge, UK). TG content in the plasma
was directly measured.
2.18. Non-esterified fatty acid content
To determine plasma NEFA levels, mice were fasted for 12 h and blood
samples were taken. The NEFA content was measured with a free fatty
acid quantification kit according to the manufacturer’s instructions
(SigmaeAldrich, St. Louis, USA).
2.19. Il-6 content
Dissected gWAT and iWAT pads were homogenized in lysis buffer
containing 100 mM NaCl, 20 mM TriseHCl, 2.5 mM EDTA and pro-
tease inhibitors (Complete Roche; Roche, Mannheim, Germany). Blood
samples were collected via the tail vein for subsequent plasma
extraction as recommended by the manufacturer’s instructions. IL-6
contents were measured according to the manufacturer’s in-
structions (R&D Systems, Minneapolis, MN, USA).
2.20. Statistical analysis
All data are presented as mean  SEM. Statistical analysis was per-
formed using a two-tailed Student’s t-test for unpaired comparison or
two-way analysis of variance (ANOVA) with the post hoc Bonferroni test
for multiple comparisons, where appropriate. Total energy expenditure
was analyzed using analysis of covariance (ANCOVA).
For all tests, p < 0.05 was considered significant (*), p < 0.01 was
considered very significant (**) and p < 0.001 was considered
extremely significant (***).
3. RESULTS
3.1. Characterization of adipocyte-specific Gnai2-deficient mice
The inducible adipocyte-specific Gnai2-deficient mouse line was
termed Gnai2ako (genotype: Gnai2fl/fl; AdipoqCreERT2þ/tg). By crossing
AdipoqCreERT2þ/tg mice [15] with mice carrying floxed Gnai2 alleles
[21], the expected genotypes were achieved. The different genotypes
were born at expected Mendelian ratios and were viable and fertile. To
induce recombination, the ligand-dependent chimeric CreER recom-
binase was activated with intraperitoneal application of tamoxifen to
recombine and excise the floxed Gnai2 DNA sequence, specifically in
adipocytes. Recombination was confirmed by genomic PCR analysis
(Supplemental Figs. 1A and B). DNA isolated from tails and adipocytes
of tamoxifen-injected ctrl (Gnai2þ/þ; adipoqCreERT2þ/tg; Gnai2fl/fl;
Gnai2þ/þ; Gnai2þ/fl) animals as well as biopsies derived from the
brain, liver, pancreas, and tails of tamoxifen-injected Gnai2ako mice
remained unaffected by CreER activity (Supplemental Fig. 1B). In
contrast, recombination was solely detectable in gonadal (gWAT;
visceral adipose tissue) and inguinal white adipose tissue (iWAT;
subcutaneous adipose tissue), and, most importantly, in DNA from
partially purified adipocytes from Gnai2ako mice indicated by the
additional 390 bp band (Supplemental Fig. 1B). To verify4 MOLECULAR METABOLISM 40 (2020) 101029  2020 The Authors. Published by Elsevier GmbH. Trecombination at the protein level in the Gnai2ako mice, immunoblot
analyses were performed to study the expression pattern of the Gai2
protein in liver, skeletal muscle, brain, BAT, gWAT, iWAT and primary
white adipocytes (WA). Using specific antibodies against the identical
COOH-terminal sequence of the Gai1 and Gai2 protein, both isoforms
were detectable in gWAT, iWAT and primary white adipocytes derived
from control and wildtype animals (Figure 1A). Interestingly, BAT only
expresses the Gai2 protein (Figure 1A). Consistent with our adipocyte-
specific mouse model, the Gai1 protein (upper band) was also
detectable in adipose tissue lysates derived from Gnai2ako and global
Gnai2-deficient mice but absent in Gnai1-deficient mice. Importantly,
its expression level was not affected by the Cre recombination in
Gnai2ako adipose tissue homogenates and primary white adipocytes
(Supplemental Figs. 1CeE). Consistent with a cell type-specific
deletion Gai2 expression levels in liver, skeletal muscle and brain
were not affected by the Cre-driven recombination in adipocytes
(Supplemental Figs. 1F and G). In contrast, the Gai2 protein (lower
band) showed a significant reduction in gWAT, iWAT and BAT of
Gnai2ako mice (Supplemental Figs. 1HeJ) and was completely absent
in global Gnai2-deficient adipose tissue lysates (Figure 1A). We
consider most of the remaining Gai2 immunoreactivity in Gnai2
ako in
gWAT, iWAT and BAT likely results from the expression of Gai2 in non-
adipose cells like vessels or connective tissue since analysis of Gai2
protein levels in primary white adipocytes revealed an 80% reduction
compared to control adipocytes (Supplemental Fig. 1K). Of note, Gai1
expression levels were not altered in Gnai2ako mice, regardless of the
diet fed arguing against any compensatory mechanisms of Gai1 for
Gai2. Hence, the adipocyte-specific knockout model for Gnai2 should
allow us to test the role of adipocyte Gai2 for body weight gain and
energy expenditure under different dietary conditions focusing on fat
cell function.
3.2. Body composition of adipocyte-specific Gnai2-deficient mice
To study the consequences of adipocyte-specific Gai2 ablation on the
metabolic homeostasis, body weight gain was recorded in adipocyte-
specific Gnai2-deficient and age- and litter-matched control mice,
receiving either a purified, low-fat control diet (CD) or a high fat diet
(HFD) with 45% of its calories derived from lipids. Animals were
allowed to recover from the tamoxifen-injections for one week before
they were subjected to the distinct diets. Before onset of the dietary
program, no differences in size or body weight were observed between
the Gnai2ako and ctrl mice (Figure 1C). Subsequently, mice deficient for
Gai2, specifically in adipocytes, gained markedly less weight following
a HFD-challenge compared to controls (Figure 1BeD). The difference
reached statistical significance after 6 weeks on HFD (12 weeks of
age) and maintained significant until the end of the study (22 weeks of
age). In contrast, mice kept under CD conditions gained much less
weight, and none of the parameters studied differed between ctrl and
Gnai2ako mice (Figures 1-5; Supplemental Figs. 4 and 5).
Obesity is defined by the excess storage of fat mass. To confirm that
total body fat mass was altered in HFD-fed Gnai2ako compared to ctrl
mice, we used magnetic resonance imaging (MRI) and time domain-
nuclear magnetic resonance (TD-NMR) approaches. HFD-fed
Gnai2ako mice displayed significantly less total fat mass compared to
ctrl mice (Figure 1EeG). In addition, the amount of visceral body fat
mass was significantly reduced at 22 weeks of age (Figure 1E,F).
Importantly, lean mass and the amount of extracellular fluid were
similar in Gnai2ako and ctrl animals (Figure 1G). In addition, neither
stool caloric content measured by bomb calorimetry, food and water
intake nor physical activity differed between HFD-fed ctrl and Gnai2ako
mice (Supplemental Fig. 2B, Figure 1HeJ). To corroborate our MRI andhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1: Reduced body weight gain in Gnai2ako mice receiving 45% HFD. (A) Representative immunoblots of gonadal (gWAT), inguinal white adipose tissue (iWAT), brown
adipose tissue (BAT) and primary white adipocyte (WA) homogenates isolated from ctrl, Gnai2ako, wild-type (wt), global Gnai2- (Gnai2/), and Gnai1- (Gnai1/) deficient mice.
The Gai2 protein is reduced in WAT, BAT and WA of Gnai2
ako and completely absent in Gnai2/ white adipose tissue. The top band indicates Gai1 expression since the antibody is
directed against the last 14 C-terminal amino acids, which are 100% identical in the Gai1 and Gai2 amino acid sequence. As a control WAT homogenates derived from Gnai1
/
mice were loaded. Equal loading was confirmed by b-actin detection. 20 mg protein were loaded in each lane. (B) Representative images from CD- and HFD-fed ctrl and Gnai2ako
mice after 22 weeks of dietary feeding. The red-dotted line indicates the silhouette of the HFD-fed control mouse. Scale bar ¼ 1 cm (C) Body weight development under CD feeding
(n ¼ 30 per genotype per time point) and HFD feeding of ctrl (n ¼ 38) and adipocyte-specific Gnai2-deficient mice (n ¼ 35). Body weight curves of Gnai2ako mice on HFD were
significantly lower compared to HFD-fed ctrl mice. Lack of Gai2 in adipocytes did not affect body weight gain of CD-fed Gnai2
ako mice in comparison to CD-fed ctrl mice. (D)
Difference (Dbw) between the initial body weight (at week 6) and the final body weight (at week 22) in Gnai2ako and ctrl mice under CD- and HFD-feeding conditions (n ¼ 27 per
genotype for CD; ctrl n ¼ 38; Gnai2ako n ¼ 35 for HFD). (E) Magnetic resonance images of cross-sections of HFD-fed ctrl and Gnai2ako mice after 16 weeks of HFD feeding (Bright
(hyperintense) areas indicate fat tissue). (F) Calculated volumes of total adipose tissue integrated over 24 slices derived during magnetic resonance imaging were quantified of
n ¼ 5 (ctrl) and n ¼ 4 (Gnai2ako) per group on HFD. TAT e total adipose tissue; VAT e visceral adipose tissue. (G) Time domain-nuclear magnetic resonance analysis revealed
significantly reduced fat masses, but similar extracellular fluid and lean mass of HFD-fed Gnai2ako mice relative to controls. Water (H), food intake (I) and physical activity (J) were
similar in HFD-fed ctrl and Gnai2ako mice. (K) Representative images of selected BAT, gWAT and iWAT fat depots of CD- or HFD-fed ctrl and Gnai2ako mice. Scale bar ¼ 1 cm. Mass
of BAT (L), gWAT (M) and iWAT (N) depots of ctrl and Gnai2ako mice receiving either a CD or HFD (ctrlCD n ¼ 28; Gnai2akoHFD n ¼ 28; ctrlHFD n ¼ 34; Gnai2akoHFD n ¼ 34). Data were
analyzed using multiple comparison two-way ANOVA followed by post-hoc comparison with Bonferroni’s multiple comparison (C, D, F, G, L-N) or the Student t test (H-J) and are
presented as means  SEMs. Statistical difference between the two genotypes is indicated: *P < 0.05, **P < 0.01, ***P < 0.001.
MOLECULAR METABOLISM 40 (2020) 101029  2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Reduced fat cell size in HFD-fed Gnai2ako mice. (A) Representative paraffin sections of gWAT derived from 28-week-old CD- (upper panel) or HFD-fed (lower panel)
ctrl and Gnai2ako animals. Scale bar ¼ 20 mm. (B) Average cell size of gWAT adipocytes after 22 weeks of CD or HFD feeding was analyzed in paraffin-embedded serial sections by
measuring the circumference of the adipocytes. Adipocytes were significantly smaller in HFD-fed Gnai2ako mice. Adipocyte size distribution in gWAT of mice fed either (C) CD or (D)
HFD (ctrlCD n ¼ 5; Gnai2akoHFD n ¼ 6; ctrlHFD n ¼ 7; Gnai2akoHFD n ¼ 11). (E) Representative paraffin sections of iWAT derived from 28-week-old CD- (upper panel) or HFD-fed
(lower panel) ctrl and Gnai2ako animals. Scale bar ¼ 20 mm. (F) Average cell size of iWAT adipocytes after 22 weeks of CD or HFD feeding was significantly reduced when analyzed
in paraffin-embedded serial sections by measuring the circumference of the adipocytes. Adipocyte size distribution in iWAT of mice fed (G) CD or (H) HFD (ctrlCD n ¼ 6; Gnai2akoHFD
n ¼ 5; ctrlHFD n ¼ 7; Gnai2akoHFD n ¼ 11). Data were analyzed using multiple comparison two-way ANOVA followed by post-hoc comparison with Bonferroni’s multiple comparison
(B-D, F-H) and are presented as means  SEMs. Statistical difference between the four treatments is indicated: *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 3: Decreased inflammatory parameters in HFD-fed Gnai2ako mice. RT-qPCR of IL-1b, osteopontin, FCεRI and TNFa in HFD-fed ctrl and Gnai2ako (A) gWAT and (B)
iWAT. (C) Representative F4/80 staining of paraffin-embedded 8 mm serial sections of gWAT derived from ctrl and Gnai2ako mice receiving either CD (upper panel) or HFD (lower
panel). (D) Statistical analysis of crown-like structure formation in CD- and HFD-fed ctrl and Gnai2ako gWAT. Significantly less CLS formation was detectable in HFD-fed Gnai2ako
gWAT. IL-6 levels measured in (E) gWAT, (F) iWAT and (G) plasma were significantly lower in HFD-fed Gnai2ako mice compared to HFD-fed ctrl. Plasma concentrations of (H) TNFa
and (I) IL-10 were significantly reduced in HFD-fed Gnai2ako mice. Data were analyzed using multiple comparison two-way ANOVA followed by post-hoc comparison with
Bonferroni’s multiple comparison (D) or the Student t test (A, B, E-I) and are presented as means  SEMs. Statistical difference between the two genotypes is indicated: *P < 0.05,
**P < 0.01, ***P < 0.001.
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Figure 4: Improved glucose handling in HFD-fed Gnai2ako mice. (A) Basal blood glucose levels of CD- and HFD-fed ctrl and Gnai2ako mice. Basal blood glucose levels were
significantly lower in HFD-fed Gnai2ako mice compared to HFD-ctrl mice. (B) Basal plasma insulin levels of HFD-fed Gnai2ako mice were significantly lower compared to HFD-fed ctrl
mice but unchanged compared to CD-fed ctrl and Gnai2ako mice. Basal plasma insulin levels were determined after 12-h fasting prior to the glucose challenge. (C) Blood glucose
levels of 28-week-old HFD-fed Gnai2ako mice were significantly lower 30, 60, and 120 min following i.p. injection of 2 mg/g body weight glucose after overnight fasting compared
to HFD-fed ctrl (ctrlHFD n ¼ 12; Gnai2akoHFD n ¼ 12). (D) Significantly lower plasma insulin levels in HFD-fed Gnai2ako mice compared to ctrl animals at all indicated time points
(ctrlHFD n ¼ 12; Gnai2akoHFD n ¼ 12). (E) Blood glucose levels measured after 4-h fasting were significantly lower in HFD-fed Gnai2ako compared to HFD-fed ctrl mice. (F)
Significantly lower blood glucose levels in HFD-fed Gnai2ako before and after 15, 30, and 60 min following the i.p. injection of 1 mU/g body weight insulin after 4-h fasting
compared to HFD-fed ctrl littermates (ctrlHFD n ¼ 12; Gnai2akoHFD n ¼ 12). Data were analyzed using multiple comparison two-way ANOVA followed by post-hoc comparison with
Bonferroni’s multiple comparison (A-F) are presented as means  SEMs. Statistical difference between the two genotypes is indicated: *P < 0.05, **P < 0.01, ***P < 0.001.
Original ArticleTD-NMR findings, we measured individual weights of brown, gonadal
and inguinal fat depots derived from CD- and HFD-fed Gnai2ako and ctrl
mice at the end of the study (Figure 1K-N). In accordance with the MRI
data, samples from inguinal and gonadal fat depot masses of HFD-fed
Gnai2ako had a reduced weight compared to HFD-ctrl animals
(Figure 1K, M, N). Taken together, these results demonstrate that in the8 MOLECULAR METABOLISM 40 (2020) 101029  2020 The Authors. Published by Elsevier GmbH. Tabsence of adipocyte Gai2 lipid storage and body weight gain is
reduced under excessive caloric intake.
Next, we analyzed livers of HFD-fed ctrl and Gnai2ako animals, which
are crucial for fat metabolism (Supplemental Fig. 3). In line with the
reduced body weight, individual liver weights were significantly
reduced (Supplemental Fig. 3A), an effect that was mitigated whenhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 5: Increased intracellular cAMP levels and ex vivo lipolysis in HFD-fed Gnai2ako mice. cAMP accumulation was measured under basal and stimulated (1 mM
norepinephrine (NE) in brown adipocyte primaries (BA) and 50 nM NE in WA) conditions in (A) BA and (B) WA isolated from HFD-fed ctrl and Gnai2ako mice. Adrenergic stimulation
resulted in significantly higher cAMP levels of HFD-fed Gnai2ako adipocytes compared to controls. (C-E) cAMP accumulation was measured under basal and stimulated (10 mM
isoproterenol (iso)) conditions in (C) gWAT, (D) iWAT and (E) BAT of HFD-fed ctrl and Gnai2ako mice for 15 min in the presence of 1 mM IBMX. Significantly more cAMP accumulated
upon adrenergic stimulation in BAT and WAT. Basal cAMP levels were significantly increased in BAT derived from Gnai2ako relative to controls. (F-H) Glycerol release was measured
in gWAT, iWAT and BAT of HFD-fed ctrl and Gnai2ako mice. The glycerol release was significantly increased upon adrenergic stimulation in gWAT, iWAT, and BAT of HFD-fed
Gnai2ako mice in comparison to ctrl animals. Basal glycerol release was significantly increased in the absence of Gai2 in BAT of HFD-fed Gnai2
ako compared to ctrl mice.
Significantly lower triglyceride levels in (I) gWAT and (J) iWAT of HFD-fed ctrl and Gnai2ako mice. (K) Significantly higher free fatty acid levels in the plasma of HFD-fed Gnai2ako
compared to HFD-fed ctrl mice. (L) Oxygen consumption rate (OCR) was measured before and after the addition of 1 mM norepinephrine (NE). Basal and NE-stimulated OCR were
significantly increased in brown adipocyte primaries isolated from Gnai2ako mice compared to ctrl mice. (M) Regression analysis of in vivo measured energy expenditure per day
and animal vs. lean body mass. Significantly higher total energy expenditure in HFD-fed Gnai2ako compared to ctrl mice. Data were analyzed using multiple comparison two-way
ANOVA followed by post-hoc comparison with Bonferroni’s multiple comparison (A-H, L), the Student t test (I-K) or ANCOVA (M) and are presented as means  SEMs. Statistical
difference between the two genotypes is indicated: *P < 0.05, **P < 0.01, ***P < 0.001.
MOLECULAR METABOLISM 40 (2020) 101029  2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Original Articleliver weight was normalized to the body weight (Supplemental Fig. 3B).
These findings correspond to the histological assessments of the livers
by H&E and Oil Red O staining that showed no differences in lipid
droplet accumulation between HFD-fed ctrl and Gnai2ako mice
(Supplemental Figs. 3C and D). Measuring hepatic triglyceride content
as an indicator of liver steatosis revealed increased, but not signifi-
cantly, triglyceride levels in HFD-fed Gnai2ako mice compared to
littermate controls (Supplementary Fig. 3E).
Adipocyte size and number determine fat mass. Therefore, we
measured adipocyte cell areas in different paraffin sections from gWAT
and iWAT of Gnai2ako and ctrl mice. gWAT and iWAT adipocytes ob-
tained from HFD-fed Gnai2ako mice were significantly smaller
compared to HFD-fed control counterparts (Figure 2AeH). BAT
morphology was similar between the two phenotypes (Supplementary
Fig. 2A).
Since enlarged hypertrophic adipocytes relate to massively increased
inflammation, we next tested whether the observed changes in
adipocyte morphology were associated with a reduced inflammatory
state in mice lacking Gai2 specifically in adipocytes. Indeed, qPCR
analysis showed that expression levels of FCεRI and the inflammatory
cytokines IL-1b, osteopontin and TNFa were significantly reduced in
gWAT and iWAT of HFD-fed Gnai2ako mice compared to controls
(Figure 3A,B). We also found a significantly reduced number of crown-
like structures, indicating enhanced inflammation of adipose tissue
following HFD-diet in the knockout mice (Figure 3C,D). F4/80
macrophage staining in HFD-fed Gnai2ako mice was almost at the level
of CD-fed Gnai2ako and ctrl mice and significantly reduced compared to
HFD-fed controls. In agreement with the reduced cytokine expression
levels and the reduced CLS formation, IL-6 levels in gWAT and iWAT as
well as IL-6, TNFa and IL-10 plasma levels were significantly lower in
HFD-fed Gnai2ako mice compared to HFD-fed control mice (Figure 3Ee
I). These data strengthen our assumption that adipocyte Gai2 is crucial
for diet-induced obesity and subsequent inflammation.
3.3. Metabolic evaluation of Gnai2ako mice
Increased fasting glucose represents an early marker for metabolic
distortion and implies an important risk factor for cardiovascular dis-
eases [22]. In addition, body fat compartments are involved in the
regulation of systemic energy balance and glucose homeostasis,
whereas CLS formation and inflammation are particularly associated
with insulin resistance. To analyze the impact of Gnai2-deficiency in
adipocytes on glucose handling and insulin resistance, we performed
i.p. glucose tolerance tests (GTT) after overnight fasting. Twenty-six-
week-old HFD-fed Gnai2ako mice already started with significantly
lower basal blood glucose and plasma insulin levels compared to HFD-
fed ctrl littermates (Figure 4A,B). Of note, basal blood glucose and
plasma insulin levels of HFD-fed Gnai2ako mice were similar to CD-fed
Gnai2ako and ctrl animals. Interestingly, during the glucose challenge
blood glucose levels were significantly lower after 30, 60 and 120 min
in HFD-fed Gnai2ako mice compared to HFD-fed controls, pointing to an
improved glucose tolerance, since HFD-feeding of ctrl animals
revealed an aggravated glucose tolerance (Figure 4C). In parallel,
plasma insulin levels were significantly lower at all indicated time
points (0, 15, 30, 60, and 120 min) in HFD-fed Gnai2ako vs ctrl animals
(Figure 4B,D). To check whether the glycemic changes are causative to
the lower body weight or rather a direct consequence of the target
deletion, 10-week old HFD-fed control and Gnai2ako mice were sub-
jected to a GTT, a time point before weight differences reached sta-
tistical significance (Figure 1C). Basal blood glucose levels and glucose
tolerance tests were similar in young HFD-fed Gnai2ako mice compared
to littermate controls arguing that the glycemic changes are causative10 MOLECULAR METABOLISM 40 (2020) 101029  2020 The Authors. Published by Elsevier GmbH. Tto the lower body weight in the knockout mice (Supplemental Figs. 4A
and B).
Fitting to the improved GTT of the 26-week-old, Gnai2ako mice, the insulin
sensitivity of HFD-fed Gnai2ako animals was significantly improved
(Figure 4E,F). Basal blood glucose levels were significantly lower already
after 4-h-fasting in HFD-fedGnai2akomice compared to littermate controls
(Figure 4E). These lower blood glucose levels remained significant at 15,
30, and 60 min after the insulin injection in the HFD-fed Gnai2ako mice
compared to ctrl littermates (Figure 4F). Interestingly, plasma non-
esterified fatty acid (NEFA) levels were markedly increased whereas
plasma triglycerides showed similar levels in HFD-fed Gnai2ako mice and
littermate controls (Figure 4G,H). These findings indicate that Gai2-defi-
ciency in adipocytes improves glucose tolerance and insulin sensitivity and
blunts diet-induced obesity.
Adipose tissue compartments exhibit functions like an endocrine or-
gan. They secrete a wide range of adipokines that regulate inflam-
mation, hunger, satiety, lipid and glucose metabolism. To test whether
the secretion of the adipokines resistin and leptin was affected in the
absence of adipocyte Gai2, we measured their plasma levels in both
CD- and HFD-fed ctrl and Gnai2ako mice after 12-h-fasting
(Supplementary Figs. 4F and G). Under HFD resistin and leptin levels
increased compared to the levels of animals receiving a CD. However,
neither resistin nor leptin levels differed between HFD-fed ctrl and
Gnai2ako mice. In contrast, mRNA expression levels of adiponectin
were significantly higher in gWAT and iWAT of the knockout mice in
comparison to control littermates (Supplemental Fig. 4H). Thus, higher
adiponectin expression levels in combination with a leaner phenotype
could point to a higher sensitivity towards the secreted adipokines in
our HFD-fed Gnai2ako animals.
3.4. Adipocyte function ex vivo
Our findings show that the specific lack of Gai2 in adipocytes provokes
a leaner phenotype by a marked reduction of fat storage upon HFD-
feeding. Next, we sought to gain insight into the underlying signaling
pathway. Gai proteins control the intracellular second-messenger
cyclic AMP (cAMP) by inhibiting adenylyl cyclases [23,24]. In unsti-
mulated primary brown and white adipocytes, BAT, gWAT and iWAT
from controls, cAMP levels were low but increased upon adrenergic
stimulation in a similar way (Figure 5AeE). Basal cAMP levels in HFD-
fed Gnai2ako brown and white adipocytes, gWAT and iWAT were similar
to those of HFD-fed controls. In contrast, cAMP levels of Gnai2ako BAT
were significantly higher compared to controls. Adrenergic stimulation
resulted in a stronger increase of intracellular cAMP concentrations in
all tissues analyzed of HFD-fed Gnai2ako mice compared to their
littermate controls (Figure 5AeE). Stimulation of adenylyl cyclase via
Gas increases lipolysis whereas Gai-driven pathways inhibit adenylyl
cyclase and reduce lipolysis in adipocytes. Thus, differences in intra-
cellular cAMP levels should affect lipolysis rates in BAT and WAT of
Gnai2ako mice. As a consequence, release of non-esterified fatty acids
and glycerol from the adipocytes should depend on cAMP levels.
Therefore we measured glycerol release from gWAT, iWAT and BAT as
an index of lipolysis. Indeed, basal lipolytic rates were significantly
higher in BAT and upon adrenergic stimulation in BAT and WAT
(Figure 5FeH). Although plasma triglycerides were similar in HFD-fed
Gnai2ako mice and littermate controls, total triglyceride levels were
significantly lower in gWAT and iWAT of HFD-fed Gnai2ako mice
compared to their HFD-fed littermate controls, whereas (Figure 5I,J,
Supplementary Fig. 5E). In line with this, fasting plasma NEFA levels
were significantly increased in the knockout mice (Figure 5K). Taken
together, Gnai2-deficiency restricted to adipocytes enhances intra-
cellular cAMP concentrations upon adrenergic stimulation. As ahis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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consequence, stored triglycerides are extensively hydrolyzed, which is
reflected in increased plasma NEFA levels.
Measuring mitochondrial oxygen consumption rate (OCR) assesses the
fuel metabolism and energy expenditure of primary white and brown
adipocytes. Therefore we performed a seahorse assay to determine
OCR of primary white and brown adipocytes. ATP-linked respiration,
maximal respiratory capacity and non-mitochondrial respiration were
not affected by the lack of Gai2 in brown and white adipocytes
(Supplementary Fig. 6 A, B). For primary white adipocytes derived from
HFD-fed Gnai2ako mice, an increased oxygen consumption rate with or
without adrenergic-stimulation was not detectable when compared to
littermate controls (Supplementary Fig. 6C). In contrast, brown adi-
pocytes showed increased oxygen consumption rates in the absence
and presence of adrenergic stimulation (Figure 5L). Of note, total en-
ergy expenditure was significantly increased in HFD-fed Gnai2ako
compared to ctrl mice (Figure 5M). Thus lack of the Gai2-isoform in
brown and white adipocytes leads to an increased energy expenditure
on HFD and impedes diet-induced obesity.
Taken together, these findings suggest that upon excessive caloric
intake, adipocyte Gai2 signaling contributes to an excessive accu-
mulation of fat mass by inhibiting adipocyte lipolysis in brown and
white adipocytes in a cAMP-dependent manner, decreasing total en-
ergy expenditure and enhancing lipid accumulation.
4. DISCUSSION
The present study examined the function of adipocyte Gai2 in fat cell
biology and its role for the metabolic state of mice under different
nutritional conditions. Mice lacking the ubiquitously expressed Gai2
protein specifically in adipocytes were studied in comparison to litter-
mate controls. Gai2-deficiency in adipocytes results in mitigated diet-
induced obesity with reduced total fat masses, smaller white adipo-
cytes, and increased total energy expenditure that was not due to dif-
ferences in food consumption or physical activity. Concomitantly,
improved glucose handling and reduced inflammation of white adipose
tissue became evident. Mechanistically, we observed increased cAMP
levels and lipolysis upon adrenergic stimulation in brown and white
adipose tissue and primary adipocytes of obese mice, accompanied by
higher oxygen consumption rates of brown adipocytes resulting in
increased total energy expenditure of the HFD-fed knockout mice.
Overall, adipose tissue-specific deletion of Gnai2 decreased weight gain
on diet-induced obesity. Our data indicate that Gai2 in adipocytes pro-
motes obesity that in turn leads to local inflammation and to systemic
glucose intolerance. Therefore we speculate that fat-cell Gai2 is a pivotal
player in the development and aggravation of diet-induced obesity that
also causes derailed metabolic alterations, such as diabetes. Our hy-
pothesis is based on several considerations detailed below.
Visceral fat and infiltrating macrophages secrete a number of medi-
ators, which play a role in the development of insulin resistance.
Among the latter are leptin, resistin, IL-6 and tumor necrosis factor-a
(TNF-a) [25e28]. Whereas plasma leptin and resistin levels were
similar in our adipocyte-specific Gnai2-deficient mice compared to
littermate controls, plasma levels of IL-6 and TNFa were significantly
decreased. Consistent with this, less crown-like structures were
formed in the gWAT of Gnai2ako mice. Crown-like structures (CLS) are
formed around dying adipocytes, an area that is infiltrated by mac-
rophages, which secrete IL-6 and TNFa. High TNFa levels correlate
positively with insulin resistance [29]. Indeed, our adipocyte-specific
Gnai2-deficient mice had improved insulin sensitivity: with lower
plasma insulin levels (basal and during glucose challenge) they
removed the glucose with higher efficiency from the blood compared toMOLECULAR METABOLISM 40 (2020) 101029  2020 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comHFD-fed controls. Thus Gnai2-deficieny prevents diet-induced
inflammation and development of insulin resistance.
The deletion of Gnai2 in brown and white adipocytes decreased weight
gain on diet-induced obesity. Our data suggest a cellular mechanism
responsible for the smaller adipocytes and the leaner phenotype in
adipocyte-specific Gnai2-deficient mice. Gnai2-deficiency produces
increased cAMP levels upon adrenergic stimulation indicating a more
efficient Gas-mediated signaling. Consequently, lipolysis is enhanced
with less triglycerides being stored in the adipocytes and thus less fat
accumulation. Our results strengthen the relevance of cAMP signaling
for the regulation of lipid metabolism. It has to be clarified whether
impaired Gai2 coupling directly to b-adrenoceptors (b1-3-AR) [30,31] or
disturbed signal transduction from a specifically Gai2-coupled receptor
fails to reduce Gas-mediated signaling in our mouse model thereby
increasing total energy expenditure. A variety of Gai-coupled receptors
has been described to act in an autocrine inhibitory fashion on white
adipocytes, e.g. lactate, nicotinic acid [32e35]. In line with our findings,
it has recently been published that acute stimulation of Gs-coupled re-
ceptors specifically in adipocytes increases ex vivo lipolysis and plasma
NEFA levels inducing hypoglycemia [36]. These results underline our
hypothesis that deletion of Gai2 enhances Gas-signaling in adipocytes.
A different approach to study how Gai2 affects obesity and metabolism
was shown in a study using a knockin mouse line in which regulator of
G-protein signaling-insensitive Gai2 (G184S) was expressed [37].
These authors find a comparable phenotype to our adipocyte-specific
Gai2 deficiency model. However, one has to be cautious with the
interpretation of these data, since the mutant is ubiquitously expressed
and the mice have a complex and severe phenotype, e.g. these mice
already start with significantly lower body weights due to growth
retardation [38]. Our mouse model lacks the Gai2 protein specifically in
adipocytes and the mutant mice do not reveal any growth or body
weight differences before onset of the HFD. In addition, several PTX-
based approaches have shown the impact of Gai proteins on inhibi-
tion of intracellular cAMP levels and lipolysis [32,39].
The presented data indicate the importance and relevance of identi-
fying Gai2especific functions in metabolically active tissues. Gai2
proteins are pertussis toxin sensitive and were supposed to inhibit
insulin secretion. Previously, we deleted Gnai2 specifically in becells
[9], which had a negative effect on glucose handling and insulin
sensitivity. In contrast to the beneficial effects of b-cell Gai2 on insulin
secretion and glucose handling, fat cell Gai2 aggravates body weight
gain, inflammation, fat storage, insulin resistance, and energy
expenditure under high caloric intake.
5. CONCLUSIONS
Collectively, our findings expand knowledge of the physiological
functions of the adipocyte Gai2 isoform in obesity and suggest inhi-
bition of Gai2-dependent signaling pathways as a potential target to
intervene in the development of excessive weight gain, obesity-
induced inflammation, and insulin resistance. Furthermore, this work
underlines the importance of understanding the metabolic roles of the
predominantly expressed Gai2 isoform in relevant insulin-dependent
tissues, and to dissect Gai1-3 isoform-specific functions in these tis-
sues for future therapeutic strategies.
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